Topics
September 2021 | 5 Questions
5Q with Matias Iglicki, MD, PHD
Matias Iglicki, MD, PHD
July/August 2021 | 5 Questions
5Q with Aaron Nagiel, MD, PHD
Aaron Nagiel, MD, PhD
May/June 2021 | 5 Questions
5Q with Netan Choudhry, MD, FRCSC
Netan Choudhry, MD, FRCSC
October 2013 | 5 Questions
Thomas Albini, MD
Dr. Albini is an Associate Professor of Clinical Ophthalmology at Bascom Palmer Eye Institute in Miami and a member of the Retina Today Editorial Board.
September 2013 | 5 Questions
John W. Kitchens, MD
Dr. Kitchens is a vitreoretinal surgeon with Retina Associates of Kentucky in Lexington and a member of the Retina Today Editorial Board.
June 24, 2026
Kalaris to Present Phase 1a Data on VEGF/HSPG Biologic at ASRS 2026
Ollin Biosciences Raises $330 Million to Advance Phase 3 Development of VEGF/Ang2 bispecific Antibody
June 23, 2026
Oculgen Announces First US Patient Enrolled in STAT Trial of OCUL101 for Wet AMD
June 22, 2026
Atsena Doses First Patient in Phase 3 LIGHTHOUSE Trial of Gene Therapy for XLRS
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
